News
- Author:
- Michele G. Sullivan
Publish date: June 4, 2019
A new study finds that about a quarter of both men and women in early middle age have osteopenia in at least one site.
News
- Author:
- Michele G. Sullivan
Publish date: May 31, 2019
DALLAS – Among patients with IPF who need anticoagulation, warfarin increased the risk of both lung transplant and death, while direct oral anticoa...
News
- Author:
- Michele G. Sullivan
Publish date: May 30, 2019
The finding may help fill out the genetic risk picture for early-onset Alzheimer’s disease.
News
- Author:
- Michele G. Sullivan
Publish date: May 24, 2019
DALLAS – By boosting innate immunity, RBT101 protects against rhinovirus respiratory infections and decreases the asthma exacerbations that can be ...
News
- Author:
- Michele G. Sullivan
Publish date: May 20, 2019
DALLAS – A decline in FVC is a good surrogate marker of mortality in interstitial lung disease associated with system...
News
- Author:
- Michele G. Sullivan
Publish date: May 8, 2019
BALTIMORE – Compared with other imaging modalities, ultrasound gives more anatomic details and costs much less.
News
- Author:
- Michele G. Sullivan
Publish date: April 23, 2019
The protein also may be useful to monitor effects in trials of disease-modifying drugs.
News
- Author:
- Michele G. Sullivan
Publish date: April 23, 2019
The use of extended half-life clotting factors was able to significantly reduce the number of infusions but the cost went up significantly.
News
- Author:
- Michele G. Sullivan
Publish date: April 23, 2019
A treat-to-target approach using total hip T scores could help guide decisions about how long women with osteoporosis should stay on bone-building ...
News
- Author:
- Michele G. Sullivan
Publish date: April 22, 2019
Canada’s community back pain clinics funnel patients with suspected axial spondyloarthritis to the rheumatologist...
News
- Author:
- Michele G. Sullivan
Publish date: April 17, 2019
Patients with better outcomes were more likely to have initiated therapy with a more potent drug.
News
- Author:
- Michele G. Sullivan
Publish date: April 16, 2019
The manufacturers didn’t provide the required safety and efficacy data in their premarket applications.
News
- Author:
- Michele G. Sullivan
Publish date: April 10, 2019
Inhibiting the APP-cleaving enzyme decreased the toxic amyloid species, but it also worsened cognition and caused a variety of concerning adverse e...
News
- Author:
- Michele G. Sullivan
Publish date: April 9, 2019
WASHINGTON – The open-label extension trial found a good maintenance of effect in patients with chronic spontaneous urticaria that is nonresponsive...
News
- Author:
- Michele G. Sullivan
Publish date: April 9, 2019
The checkpoint inhibitor was especially effective in patients with PD-L1-positive tumors.
